Top 20 biopharmaceutical companies hold their spot despite …
https://www.pharmaceutical-technology.com/comment/top-20-biopharmaceutical-companies/
WEBMay 3, 2022 · The majority of the top 20 global biopharmaceutical companies continued their growth and experienced a favorable Q1 2022, retaining their position from Q4 2021. An overall 2.1% growth in aggregate market cap was reported over Q4, from $3.4 trillion on December 31, 2021 to $3.5 trillion on March 31, 2022. This led to a positive market cap …
DA: 28 PA: 88 MOZ Rank: 67